Cargando…

Scleromyxedema with Subcutaneous Nodules: Successful Treatment with Thalidomide and Intravenous Immunoglobulin

Scleromyxedema is a rare cutaneous mucinosis, usually presenting with generalized papular eruption and sclerodermoid induration, monoclonal gammopathy and systemic manifestations. An atypical clinical presentation with cutaneous and subcutaneous nodules has been reported rarely. In recent years, int...

Descripción completa

Detalles Bibliográficos
Autores principales: Dolenc-Voljč, M., Jurčić, V., Hočevar, A., Tomšič, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3843934/
https://www.ncbi.nlm.nih.gov/pubmed/24348379
http://dx.doi.org/10.1159/000356469
_version_ 1782293117294084096
author Dolenc-Voljč, M.
Jurčić, V.
Hočevar, A.
Tomšič, M.
author_facet Dolenc-Voljč, M.
Jurčić, V.
Hočevar, A.
Tomšič, M.
author_sort Dolenc-Voljč, M.
collection PubMed
description Scleromyxedema is a rare cutaneous mucinosis, usually presenting with generalized papular eruption and sclerodermoid induration, monoclonal gammopathy and systemic manifestations. An atypical clinical presentation with cutaneous and subcutaneous nodules has been reported rarely. In recent years, intravenous immunoglobulin (IVIg) appears to be the therapy of choice for scleromyxedema. Treatment experiences in atypical manifestations with mucinous nodules are limited to sporadic reports. We report the case of male patient with atypical scleromyxedema without underlying paraproteinemia, presenting with generalized papular and sclerodermoid skin eruption and multiple nodular mucinous lesions on the fingers and face as well as on the eyelids, and associated systemic symptoms. Complete regression of all cutaneous lesions and extracutaneous symptoms with sustained remission was achieved by combined treatment with thalidomide and IVIg.
format Online
Article
Text
id pubmed-3843934
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-38439342013-12-12 Scleromyxedema with Subcutaneous Nodules: Successful Treatment with Thalidomide and Intravenous Immunoglobulin Dolenc-Voljč, M. Jurčić, V. Hočevar, A. Tomšič, M. Case Rep Dermatol Published online: November, 2013 Scleromyxedema is a rare cutaneous mucinosis, usually presenting with generalized papular eruption and sclerodermoid induration, monoclonal gammopathy and systemic manifestations. An atypical clinical presentation with cutaneous and subcutaneous nodules has been reported rarely. In recent years, intravenous immunoglobulin (IVIg) appears to be the therapy of choice for scleromyxedema. Treatment experiences in atypical manifestations with mucinous nodules are limited to sporadic reports. We report the case of male patient with atypical scleromyxedema without underlying paraproteinemia, presenting with generalized papular and sclerodermoid skin eruption and multiple nodular mucinous lesions on the fingers and face as well as on the eyelids, and associated systemic symptoms. Complete regression of all cutaneous lesions and extracutaneous symptoms with sustained remission was achieved by combined treatment with thalidomide and IVIg. S. Karger AG 2013-11-02 /pmc/articles/PMC3843934/ /pubmed/24348379 http://dx.doi.org/10.1159/000356469 Text en Copyright © 2013 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial 3.0 Unported license (CC BY-NC) (www.karger.com/OA-license), applicable to the online version of the article only. Users may download, print and share this work on the Internet for noncommercial purposes only, provided the original work is properly cited, and a link to the original work on http://www.karger.com and the terms of this license are included in any shared versions.
spellingShingle Published online: November, 2013
Dolenc-Voljč, M.
Jurčić, V.
Hočevar, A.
Tomšič, M.
Scleromyxedema with Subcutaneous Nodules: Successful Treatment with Thalidomide and Intravenous Immunoglobulin
title Scleromyxedema with Subcutaneous Nodules: Successful Treatment with Thalidomide and Intravenous Immunoglobulin
title_full Scleromyxedema with Subcutaneous Nodules: Successful Treatment with Thalidomide and Intravenous Immunoglobulin
title_fullStr Scleromyxedema with Subcutaneous Nodules: Successful Treatment with Thalidomide and Intravenous Immunoglobulin
title_full_unstemmed Scleromyxedema with Subcutaneous Nodules: Successful Treatment with Thalidomide and Intravenous Immunoglobulin
title_short Scleromyxedema with Subcutaneous Nodules: Successful Treatment with Thalidomide and Intravenous Immunoglobulin
title_sort scleromyxedema with subcutaneous nodules: successful treatment with thalidomide and intravenous immunoglobulin
topic Published online: November, 2013
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3843934/
https://www.ncbi.nlm.nih.gov/pubmed/24348379
http://dx.doi.org/10.1159/000356469
work_keys_str_mv AT dolencvoljcm scleromyxedemawithsubcutaneousnodulessuccessfultreatmentwiththalidomideandintravenousimmunoglobulin
AT jurcicv scleromyxedemawithsubcutaneousnodulessuccessfultreatmentwiththalidomideandintravenousimmunoglobulin
AT hocevara scleromyxedemawithsubcutaneousnodulessuccessfultreatmentwiththalidomideandintravenousimmunoglobulin
AT tomsicm scleromyxedemawithsubcutaneousnodulessuccessfultreatmentwiththalidomideandintravenousimmunoglobulin